NCT03511027 is a NA clinical trial of SME + Karie Device in Medication Adherence, sponsored by Lee Verweel.

Who is sponsoring NCT03511027?

NCT03511027 is sponsored by Lee Verweel.

What drugs are being tested in NCT03511027?

Interventions in NCT03511027: SME + Karie Device, SME only.

What condition does NCT03511027 study?

NCT03511027 studies Medication Adherence, Cognitive Impairment.

Is NCT03511027 still recruiting?

NCT03511027 is currently withdrawn. Last updated 3 May 2022.

Last reviewed 2022-05-03 · How we verify

NCT03511027

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medication Dispenser to Improve Care at Home for the Elderly

Withdrawn NA Last updated 3 May 2022

What this trial tests

NA trial testing SME + Karie Device in Medication Adherence. Withdrawn.

Timeline

1 August 2018

Primary endpoint
1 September 2019

1 October 2020

Quick facts

Lead sponsor	Lee Verweel
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Start date	1 August 2018
Primary completion	1 September 2019
Estimated completion	1 October 2020

Drugs / interventions tested

SME + Karie Device
SME only

Conditions studied

Medication Adherence — all drugs for Medication Adherence →
Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

Lee Verweel

Who can join

18 and older, any sex, with Medication Adherence or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the efficacy of the Karie Automated Medication delivery device in enhancing medication adherence among a group of elderly patients with mild to moderate cognitive decline.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.
Cross AJ, Elliott RA, Petrie K, Kuruvilla L, et al · · 2020 · cited 135× · PMID 32383493 · DOI 10.1002/14651858.cd012419.pub2

Verify or expand the search:

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

NCT07420634 — Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes · recruiting
NCT06876233 — Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication · NA · recruiting
NCT05624931 — Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa · NA · recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
NCT06569290 — Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Sci · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03511027 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lee Verweel
Last refreshed: 3 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511027.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing